Indawati De Lucca

Discovery of Milvexian, a High-Affinity, Orally Bioavailable Inhibitor of Factor XIa in Clinical Studies for Antithrombotic Therapy

Andrew K. Dilger, Kumar B. Pabbisetty, James R. Corte et al. · Journal of Medicinal Chemistry · 2021 · 97 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

P1 Phenethyl peptide boronic acid inhibitors of HCV NS3 protease

E. Scott Priestley, Indawati De Lucca, Bahman Ghavimi et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 62 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

Stereospecific Synthesis, Structure−Activity Relationship, and Oral Bioavailability of Tetrahydropyrimidin-2-one HIV Protease Inhibitors

George V. De Lucca, Jing Liang, Indawati De Lucca · Journal of Medicinal Chemistry · 1998 · 54 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Discovery and gram-scale synthesis of BMS-593214, a potent, selective FVIIa inhibitor

E. Scott Priestley, Indawati De Lucca, Jinglan Zhou et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 27 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +8

Selection of a Thiazole Urea-Resistant Variant of Bovine Viral Diarrhoea Virus That Maps to the RNA-Dependent RNA Polymerase

Robert W. King, Helen Scarnati, E. Scott Priestley et al. · Antiviral chemistry & chemotherapy · 2002 · 16 citations · Full text

Life Sciences, Microbiology, Molecular Biology +17